361 related articles for article (PubMed ID: 20164327)
1. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
Zhang J; Huang XY; Ye ML; Luo CX; Wu HY; Hu Y; Zhou QG; Wu DL; Zhu LJ; Zhu DY
J Neurosci; 2010 Feb; 30(7):2433-41. PubMed ID: 20164327
[TBL] [Abstract][Full Text] [Related]
2. Extracellular regulated protein kinaseis critical for the role of 5-HT1a receptor in modulating nNOS expression and anxiety-related behaviors.
Cai CY; Wu HY; Luo CX; Zhu DY; Zhang Y; Zhou QG; Zhang J
Behav Brain Res; 2019 Jan; 357-358():88-97. PubMed ID: 29246772
[TBL] [Abstract][Full Text] [Related]
3. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.
Turcotte-Cardin V; Vahid-Ansari F; Luckhart C; Daigle M; Geddes SD; Tanaka KF; Hen R; James J; Merali Z; Béïque JC; Albert PR
J Neurosci; 2019 Feb; 39(8):1334-1346. PubMed ID: 30552180
[TBL] [Abstract][Full Text] [Related]
4. Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis.
Stewart A; Maity B; Wunsch AM; Meng F; Wu Q; Wemmie JA; Fisher RA
FASEB J; 2014 Apr; 28(4):1735-44. PubMed ID: 24421401
[TBL] [Abstract][Full Text] [Related]
5. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
[TBL] [Abstract][Full Text] [Related]
6. Requirement of hippocampal DG nNOS-CAPON dissociation for the anxiolytic and antidepressant effects of fluoxetine.
Shi HJ; Wu DL; Chen R; Li N; Zhu LJ
Theranostics; 2022; 12(8):3656-3675. PubMed ID: 35664081
[No Abstract] [Full Text] [Related]
7. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment.
Kantor S; Graf M; Anheuer ZE; Bagdy G
Eur Neuropsychopharmacol; 2001 Feb; 11(1):15-24. PubMed ID: 11226808
[TBL] [Abstract][Full Text] [Related]
8. 5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats.
Solati J; Salari AA; Bakhtiari A
Neurosci Lett; 2011 Oct; 504(3):325-9. PubMed ID: 21982809
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors.
Eriksson TM; Holst S; Stan TL; Hager T; Sjögren B; Ogren SÖ; Svenningsson P; Stiedl O
Neuropharmacology; 2012 Nov; 63(6):1150-60. PubMed ID: 22801295
[TBL] [Abstract][Full Text] [Related]
10. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
[TBL] [Abstract][Full Text] [Related]
11. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model.
Cervo L; Mocaër E; Bertaglia A; Samanin R
Neuropharmacology; 2000 Apr; 39(6):1037-43. PubMed ID: 10727714
[TBL] [Abstract][Full Text] [Related]
12. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
Guptarak J; Sarkar J; Hiegel C; Uphouse L
Horm Behav; 2010 Jul; 58(2):290-6. PubMed ID: 20223238
[TBL] [Abstract][Full Text] [Related]
13. Mice deficient in the alpha subunit of G(z) show changes in pre-pulse inhibition, anxiety and responses to 5-HT(1A) receptor stimulation, which are strongly dependent on the genetic background.
van den Buuse M; Martin S; Holgate J; Matthaei K; Hendry I
Psychopharmacology (Berl); 2007 Dec; 195(2):273-83. PubMed ID: 17684732
[TBL] [Abstract][Full Text] [Related]
14. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
Collinson N; Dawson GR
Psychopharmacology (Berl); 1997 Jul; 132(1):35-43. PubMed ID: 9272757
[TBL] [Abstract][Full Text] [Related]
15. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
Zhang H; Wang W; Jiang Z; Shang J; Zhang L
Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
[TBL] [Abstract][Full Text] [Related]
16. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects.
Bortolozzi A; Castañé A; Semakova J; Santana N; Alvarado G; Cortés R; Ferrés-Coy A; Fernández G; Carmona MC; Toth M; Perales JC; Montefeltro A; Artigas F
Mol Psychiatry; 2012 Jun; 17(6):612-23. PubMed ID: 21808255
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic control of ingestive and post-ingestive behaviors in pigeons (Columba livia): the role of 5-HT1A receptor-mediated central mechanisms.
Hoeller AA; Dos Santos TS; Bruxel RR; Dallazen AR; do Amaral Silva HT; André ES; Marino-Neto J
Behav Brain Res; 2013 Jan; 236(1):118-130. PubMed ID: 22954717
[TBL] [Abstract][Full Text] [Related]
18. Testosterone promotes anxiolytic-like behavior in gonadectomized male rats via blockade of the 5-HT
Fedotova J; Hritcu L
Gen Comp Endocrinol; 2017 Dec; 254():14-21. PubMed ID: 28919453
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats.
Wesołowska A; Paluchowska MH; Gołembiowska K; Chojnacka-Wójcik E
J Pharm Pharmacol; 2003 Apr; 55(4):533-43. PubMed ID: 12803776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
